Navigation Links
Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
Date:9/7/2011

toacidosis.

TRADJENTA has not been studied in combination with insulin.

Important Safety InformationCONTRAINDICATIONSTRADJENTA is contraindicated in patients with a history of hypersensitivity reaction to linagliptin, such as urticaria, angioedema or bronchial hyperreactivity.

WARNINGS AND PRECAUTIONSUse with Medications Known to Cause HypoglycemiaInsulin secretagogues (e.g., sulfonylurea) are known to cause hypoglycemia. Therefore, a lower dose of the insulin secretagogue may be required to reduce the risk of hypoglycemia when used in combination with TRADJENTA.

Macrovascular OutcomesThere have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with TRADJENTA or any other antidiabetic drug.

ADVERSE REACTIONSAdverse reactions reported in >/=5% of patients treated with TRADJENTA and more commonly than in patients treated with placebo included nasopharyngitis.

Hypoglycemia was more commonly reported in patients treated with the combination of TRADJENTA and sulfonylurea compared with those treated with the combination of placebo and sulfonylurea. Pancreatitis was reported more often in patients randomized to linagliptin (1 per 538 person-years versus zero in 433 person-years for comparator).

DRUG INTERACTIONSThe efficacy of TRADJENTA may be reduced when administered in combination with a strong P-glycoprotein or CYP3A4 inducer (e.g., rifampin). Therefore, use of alternative treatments is strongly recommended.

USE IN SPECIFIC POPULATIONSThere are no adequate and well-controlled studies in pregnant women. Therefore, TRADJENTA should be used during pregnancy only if clearly needed. It is not known whether linagliptin is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when TRADJENTA is administered to a nursing woman. Safety and effectiveness of TRADJENTA in patients below the age of 18 have not been esta
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DARTâ„¢-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today that on December 24, ... offering. The Company raised approximately $2.3 ... intends to use the net proceeds from the ...
(Date:12/24/2014)... and LONDON , December 24, ... industry are expected to grow at an average rate ... of value and volume. Hip, knee and spine surgeries ... while in emerging economies they have a lower penetration. ... challenging the use of composites. Non-metallic orthopedic devices have ...
(Date:12/24/2014)... DALLAS , December 24, 2014 /PRNewswire/ ... Research Report on Global Disposable Syringe Industry ... to its online business intelligence library. ... Global Disposable Syringe Industry is a professional ... Syringe market.  For overview analysis, the report ...
Breaking Medicine Technology:Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
... SPRINGS, Fla., Oct. 8 The most comprehensive, ... and regulations is now available from Point of ... information technology (HIT) strategy and management consulting firm ... health records, health information exchanges and personal health ...
... Millennium Research Group (MRG), the global authority on medical ... surgical lights will represent 100% of surgical light sales ... longer lasting LED lights. MRG,s European Markets for ... report finds that adoption will be accelerated in Europe, ...
Cached Medicine Technology:Newly Updated Pharmacy State Law Compendium Available 2LEDs To Completely Replace Halogen Lights in the European Surgical Market By 2014 2LEDs To Completely Replace Halogen Lights in the European Surgical Market By 2014 3
(Date:12/24/2014)... Dennis Thompson HealthDay Reporter ... news about the experimental Ebola vaccine that U.S. officials are ... shows a precursor of that vaccine produced a safe and ... the vaccine, when given to more than 100 Ugandans in ... blood cells that could potentially protect a person against infection ...
(Date:12/24/2014)... -- Longer and colder body cooling does not reduce the ... a lack of oxygen, a new study finds. The ... -- called hypoxic ischemic encephalopathy -- can be reduced by ... for 72 hours, experts say. Research has shown that ... this study examined if the same would be true in ...
(Date:12/24/2014)... News) -- Though most patients with obsessive-compulsive disorder (OCD) ... 10 percent to 20 percent have a form of ... say. However, patients with this so-called "refractory OCD" ... of brain surgery that disables certain brain networks believed ... between patients most likely to benefit from the surgery, ...
(Date:12/24/2014)... TUESDAY, Dec. 23, 2014 (HealthDay News) -- If you ... off if you are not treated by a cardiologist, ... actually improved when cardiologists left town for annual professional ... with cardiac arrest who were admitted to a teaching ... days, but 70 percent died when these meetings were ...
(Date:12/22/2014)... December 22, 2014 As part ... senior care service in San Diego and ... of its senior care team with ongoing online ... Golden Care is provided by Caregiverlist®. Caregiverlist® ... caregivers with the most reliable eldercare options, highest ...
Breaking Medicine News(10 mins):Health News:Early Study Offers Hope for an Ebola Vaccine 2Health News:Early Study Offers Hope for an Ebola Vaccine 3Health News:Early Study Offers Hope for an Ebola Vaccine 4Health News:Greater Cooling of Oxygen-Deprived Infants Fails to Improve Survival 2Health News:Scans May Spot People Who'll Benefit From Surgery for OCD 2Health News:When Heart Docs Are Away, Their High-Risk Patients May Fare Better 2Health News:When Heart Docs Are Away, Their High-Risk Patients May Fare Better 3Health News:Golden Care Partners with Nationally Recognized Caregiver Training Service 2
... The Madras Institute of Trauma (MIOT) deserves to be called ... minimally invasive surgery (MIS) for all kinds of surgeries. // ... that provides 40 fold magnification of a specific body ... liver, cardiac bypass, surgical excision of brain tumor, spinal injury ...
... cell research in the state with the approval of 61% ... have impeded the initiative. // ,The officials now ... will be initiated. Zach Hall, president of the California Institute ... would commence the project as soon as possible. ...
... head of Psycho and Geriatrics Ward at the Punjab Institute of ... their relatives after they have been declared mentally fit by doctors. ... such patients who have completely recovered but no place to go. ... members they say that these patients are of no use and ...
... rushing off at lunch breaks, coughing up ?4,500 for Jiffy ... for such breast implant operations//, and is getting into the ... Kirkham was one of the first to be on their ... by her mom and a student loan. She said: ...
... buster, pain reliever, sleep-inducer, hair conditioner and wrinkle remover, ... guessing! Intimate sex with your partner can provide the much ... NHS helpline says "Forget about jogging round the block or ... fact, good bout of 'sexercise'." ,The NHS site ...
... has spent the last two decades in chains in a ... Pradesh//. His family said that Mansharam did not move at ... ,His brother Bhogchand says that Mansharam was chained to a ... "We spent a lot of money to get him treated ...
Cached Medicine News:Health News:Any Form Of Minimally Invasive Surgery- Name It & They Do It! 2Health News:Momentum of Stem cell research impeded by legal challenges 2Health News:Is mental illness a social stigma? 2
... pacemaker family, which includes the world's ... the most advanced pacemaker technology available, ... the first and only U.S. commercially ... fibrillation (AF). The AF Suppression algorithm ...
... the real-time monitoring surveillance of a ... tools. Moreover, the Information Center is ... so that monitoring data can be ... radiology images, archived data, lab results, ...
... system uses catheters that are controlled ... console. The console processes the refrigerant, ... tip of the catheter, creates cryogenic ... an easy-to-use touch-screen interface. From this ...
... tasks and delivers consistently reliable ... and ensure testing accuracy in ... automated reticulocyte counts and three-dimensional ... sensitivity, specificity and efficiency in ...
Medicine Products: